MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 166001 to 166020 of 166,322 approvalsPage 8301 of 8317

祛痰止咳颗粒

Approval Number: 国药准字Z44020143
Registration: Jun 27, 2019

Ibuprofen Tablets

Approval Number: 国药准字H44020102
Registration: Jun 27, 2019

鹅去氧胆酸

Approval Number: 国药准字H21024281
Registration: Jun 27, 2019

Sulfadiazine Silver Cream

Approval Number: 国药准字H20094208
Registration: Jun 27, 2019

表虚感冒胶囊

Approval Number: 国药准字Z20090914
Registration: Jun 27, 2019

NA

Approval Number: 国药准字Z44020081
Registration: Jun 27, 2019

Sodium Chloride Injection

Approval Number: 国药准字H20093915
Registration: Jun 27, 2019

北豆根滴丸

Approval Number: 国药准字Z20090834
Registration: Jun 27, 2019

Flunarizine Hydrochloride Tablets

Approval Number: 国药准字H20023105
Registration: Jun 27, 2019

乌鸡白凤丸

Approval Number: 国药准字Z44020157
Registration: Jun 27, 2019

Azithromycin Tablets

Approval Number: 国药准字H20073845
Registration: Jun 27, 2019

银翘解毒颗粒

Approval Number: 国药准字Z44020330
Registration: Jun 27, 2019

Compound Sulfamethoxazole Tablets

Approval Number: 国药准字H44020103
Registration: Jun 27, 2019

炎可宁胶囊

Approval Number: 国药准字Z20050025
Registration: Jun 27, 2019

Insulin Degludec and Insulin Aspart Injection

Approval Number: 国药准字J20190016
Registration: Jun 27, 2019

Glucose Injection

Approval Number: 国药准字H20094104
Registration: Jun 27, 2019

归芍调经胶囊

Approval Number: 国药准字Z20090923
Registration: Jun 27, 2019

Insulin Degludec and Insulin Aspart Injection

Approval Number: 国药准字J20190017
Registration: Jun 27, 2019

熊去氧胆酸

Approval Number: 国药准字H21024282
Registration: Jun 27, 2019

小儿咳喘灵泡腾片

Approval Number: 国药准字Z20090931
Registration: Jun 27, 2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.